A sleep specialist and an endocrinologist discuss ways to engage patients in difficult conversations and shared decision-making to better manage the related conditions of sleep apnea and obesity.

Hypertension commonly co-exists with obstructive sleep apnea (OSA). However, the role of renin-angiotensin-aldosterone system (RAAS) in the development of hypertension in OSA patients remains poorly ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

New research highlights that severe obstructive sleep apnea (OSA) independently predicts elevated C-reactive protein (CRP) ...

More specifically, Zepbound received approval for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity, alongside a reduced-calorie diet and increased physical activity.

Snoring, often dismissed as a mere annoyance, can be a potentially life-threatening condition of obstructive sleep apnea (OSA ...

Strong associations were observed for obstructive sleep apnea, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease. Obesity is a risk factor for adverse health outcomes ...

While the strongest evidence exists that getting sufficient sleep (duration of sleep) is important for overall health , other ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

“It's called GLP one receptor,” said Atul Malhotra, MD from the UC San Diego School of Medicine. It’s already FDA-approved to manage diabetes and obesity — now, researchers at UC San Diego have gotten ...

Fortis Hospital Bannerghatta Road, Bengaluru has successfully performed a robot-aided bariatric surgery on a 35-year-old man ...